Researchers combat cancer, Parkinson’s with CRISPR – The Stanford Daily
The Stanford Daily |
Researchers combat cancer, Parkinson’s with CRISPR
The Stanford Daily Research from Stanford’s Qi Lab and published in Nature Communications is honing in on a method of using gene-editing to further the fight against leukemia and potentially other cancers. Bioengineering and chemical systems biology professor Stanley Qi … |
|
SVCE students win global award
Business Line Thirteen students of the Chennai-based Sri Venkateswara College of Engineering (SVCE) have won the silver medal in ‘iGEM 2017’ competition. The iGEM is an international biotechnology competition held in Boston every year; SVCE students have won an … |
|
Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema …
GlobeNewswire (press release) Herantis Pharma Plc (“Herantis”) has completed the patient enrolment in the clinical Phase 1 safety and tolerability study with the company’s investigational gene therapy product Lymfactin® for the treatment of breast cancer associated secondary … |
New Jersey Herald |
2nd man undergoes gene editing; no major side effects showing so far
New Jersey Herald A second patient has been treated in a historic gene editing study in California, and no major side effects or safety issues have emerged from the first man’s treatment nearly three months ago, doctors revealed Tuesday. Gene editing is a more precise … |
New Atlas |
New CRISPR method strategically targets gene mutations to correct DMD heart defect
New Atlas Researchers at UT Southwestern Medical Center have developed a CRISPR technique to efficiently correct the function of heart cells in patients with Duchenne muscular dystrophy (DMD). It involves making a single cut at strategic points along patient’s … |